Health Condition 1: L638- Other alopecia areata
Conditions
Interventions
Intervention1: Intralesional steroid -triamcinolone acetonide(5mg /ml): Intralesional steroid ( triamcinolone acetonide 5 mg/ml ) given intradermally in small volumes of 0.1 ml once in 4 weeks on week
Sponsors
SRM Medical College Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients of 18 years of age and above attending SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER dermatology OPD, diagnosed with alopecia areata. 2. Patients having 1-5 patches on the scalp. 3. Patients who have not received any hair related treatment in the past 3 months 4. Patients providing voluntary informed and written consent for the explained treatment modality to be performed.
Exclusion criteria
Exclusion criteria: 1. Other types of AA such as ophiasis, sisapho, totalis , universalis 2. Patients with single alopecic patch greater than 6x6 sq.cm Total area of all patches combined should not exceed 80 sq.cm 3. Pregnancy or breastfeeding 4. Infection 5. Other immunological disorders and endocrine diseases which causes hair loss 6. Photosensitive skin 7. Patients unwilling to continue cooperation in the trial 8. Progressive AA during the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Extent and density of regrowth by the SALT scoring systemTimepoint: Week 0, 4 ,8 ,12 , 16 20 and 24 | — |
Secondary
| Measure | Time frame |
|---|---|
| Global Aesthetic Improvement Scale, Patient satisfaction scoreTimepoint: Week 24;Visual Analogue ScaleTimepoint: Week 0, 4 ,8 ,12 , 16, 20 and 24 | — |
Countries
India
Contacts
Public ContactAllam Priyanka Reddy
SRM Medical College Hospital and Research Centre
Outcome results
None listed